Zomedica Corp.
ZOMDF
$0.041
$0.00194.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.36M | 27.52M | 27.29M | 26.73M | 26.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.36M | 27.52M | 27.29M | 26.73M | 26.08M |
| Cost of Revenue | 8.68M | 8.15M | 8.20M | 8.12M | 8.16M |
| Gross Profit | 19.68M | 19.38M | 19.09M | 18.61M | 17.91M |
| SG&A Expenses | 44.30M | 45.39M | 46.85M | 48.65M | 47.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.71M | 60.88M | 62.31M | 64.99M | 62.84M |
| Operating Income | -32.35M | -33.36M | -35.03M | -38.26M | -36.77M |
| Income Before Tax | -85.39M | -102.08M | -47.54M | -62.07M | -57.76M |
| Income Tax Expenses | -293.00K | -448.00K | -557.00K | 123.00K | -1.77M |
| Earnings from Continuing Operations | -85.10 | -101.63 | -46.98 | -62.19 | -55.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -85.10M | -101.63M | -46.98M | -62.19M | -55.99M |
| EBIT | -32.35M | -33.36M | -35.03M | -38.26M | -36.77M |
| EBITDA | -24.14M | -25.09M | -27.04M | -30.45M | -29.39M |
| EPS Basic | -0.09 | -0.10 | -0.05 | -0.06 | -0.06 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.10 | -0.11 | -0.06 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Average Diluted Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |